Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Report

Global and China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 18, 2022
  • PAGES：223
  • REPORT CODE：GMM1386519
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Biogen

    • Novartis AG

    • Bristol-Myers Squibb Company

    • Amgen Inc

    • AbbVie Inc

    • Johnson & Johnson Services, Inc

    • Pfizer Inc

    • GlaxoSmithKline plc

    • Merck & Co, Inc

    • Eli Lilly and Company

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Aspirin

    • Ibuprofen

    • Naproxen

    • Celecoxib

    • Others

    Application:

    • Drug Store

    • Hospital Pharmacies

    • Online

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Overview

      • 1.1.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Scope and Market Segments

      • 1.1.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Characteristics

      • 1.1.3 Global and China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Production Value and Growth Rate (2017-2028)

    • 1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Aspirin

      • 1.2.2 Ibuprofen

      • 1.2.3 Naproxen

      • 1.2.4 Celecoxib

      • 1.2.5 Others

    • 1.3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Drug Store

      • 1.3.2 Hospital Pharmacies

      • 1.3.3 Online

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Porter's Five Forces Model Analysis

      • 2.2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry PEST Analysis

    • 2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry

    Chapter 3 Global and China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, by Manufacturer

    • 3.1 Global and China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Top 3 Players

    Chapter 4 Global and China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, by Type (2017-2028)

    • 4.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Trend, by Type

    • 4.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Price Trend, by Type (2017-2028)

    • 4.3 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Analysis

    • 7.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, by Type

    • 7.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, by Application

    • 7.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Analysis and Forecast, by Country

      • 7.3.1 United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Analysis

    • 8.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, by Type

    • 8.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, by Application

    • 8.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Analysis and Forecast, by Country

      • 8.3.1 Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Analysis

    • 9.1 APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, by Type

    • 9.2 APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, by Application

    • 9.3 APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Analysis and Forecast, by Country

      • 9.3.1 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Analysis

    • 10.1 Latin America, Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, by Type

    • 10.2 Latin America, Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, by Application

    • 10.3 Latin America, Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Company Profiles

      • 11.1 Biogen

        • 11.1.1 Biogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Biogen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Profiles, Application and Specification

        • 11.1.3 Biogen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Novartis AG

        • 11.2.1 Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Novartis AG Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Profiles, Application and Specification

        • 11.2.3 Novartis AG Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Bristol-Myers Squibb Company

        • 11.3.1 Bristol-Myers Squibb Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Bristol-Myers Squibb Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Profiles, Application and Specification

        • 11.3.3 Bristol-Myers Squibb Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Amgen Inc

        • 11.4.1 Amgen Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Amgen Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Profiles, Application and Specification

        • 11.4.3 Amgen Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 AbbVie Inc

        • 11.5.1 AbbVie Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 AbbVie Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Profiles, Application and Specification

        • 11.5.3 AbbVie Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Johnson & Johnson Services, Inc

        • 11.6.1 Johnson & Johnson Services, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Johnson & Johnson Services, Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Profiles, Application and Specification

        • 11.6.3 Johnson & Johnson Services, Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Pfizer Inc

        • 11.7.1 Pfizer Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Pfizer Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Profiles, Application and Specification

        • 11.7.3 Pfizer Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 GlaxoSmithKline plc

        • 11.8.1 GlaxoSmithKline plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 GlaxoSmithKline plc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Profiles, Application and Specification

        • 11.8.3 GlaxoSmithKline plc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Merck & Co, Inc

        • 11.9.1 Merck & Co, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Merck & Co, Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Profiles, Application and Specification

        • 11.9.3 Merck & Co, Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Eli Lilly and Company

        • 11.10.1 Eli Lilly and Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Profiles, Application and Specification

        • 11.10.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Investment Prospect and Risk Assessment

    • 12.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Production Value and Growth Rate (2017-2028)

    • Figure China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Production Value and Growth Rate (2017-2028)

    • Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Growth Rate of Aspirin (2017-2028)

    • Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Growth Rate of Ibuprofen (2017-2028)

    • Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Growth Rate of Naproxen (2017-2028)

    • Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Growth Rate of Celecoxib (2017-2028)

    • Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Growth Rate of Drug Store (2017-2028)

    • Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Growth Rate of Hospital Pharmacies (2017-2028)

    • Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Growth Rate of Online (2017-2028)

    • Figure North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share, by Manufacturer in 2021

    • Figure Global and China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share, by Manufacturer in 2022

    • Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, by Type (2017-2028)

    • Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share, by Type (2017-2028)

    • Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share, by Type (2017-2028)

    • Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value, by Type (2017-2028)

    • Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value Share, by Type (2017-2028)

    • Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Price Trend, by Type (2017-2028)

    • Table China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, by Type (2017-2028)

    • Table China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share, by Type (2017-2028)

    • Figure China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share, by Type (2017-2028)

    • Table China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value, by Type (2017-2028)

    • Table China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value Share, by Type (2017-2028)

    • Figure China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Price Trend, by Type (2017-2028)

    • Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, by Application (2017-2028)

    • Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share, by Application (2017-2028)

    • Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share, by Application (2017-2028)

    • Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value, by Application (2017-2028)

    • Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value Share, by Application (2017-2028)

    • Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value Share, by Application (2017-2028)

    • Table China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, by Application (2017-2028)

    • Table China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share, by Application (2017-2028)

    • Figure China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share, by Application (2017-2028)

    • Table China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value, by Application (2017-2028)

    • Table China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value Share, by Application (2017-2028)

    • Figure China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value Share, by Application (2017-2028)

    • Figure China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Production, Import, Consumption and Export (2017-2022)

    • Figure North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Production, Import, Consumption and Export (2017-2022)

    • Table North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, by Type (2017-2028)

    • Table North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share, by Type (2017-2028)

    • Figure North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share, by Type (2017-2028)

    • Table North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, by Application (2017-2028)

    • Table North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share, by Application (2017-2028)

    • Figure North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share, by Application (2017-2028)

    • Figure United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Growth Rate (2017-2028)

    • Figure Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Growth Rate (2017-2028)

    • Table Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, by Type (2017-2028)

    • Table Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share, by Type (2017-2028)

    • Figure Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share, by Type (2017-2028)

    • Table Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, by Application (2017-2028)

    • Table Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share, by Application (2017-2028)

    • Figure Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share, by Application (2017-2028)

    • Figure Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Growth Rate (2017-2028)

    • Figure UK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure UK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Growth Rate (2017-2028)

    • Figure France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Growth Rate (2017-2028)

    • Figure Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Growth Rate (2017-2028)

    • Figure Spain Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Growth Rate (2017-2028)

    • Figure Poland Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Growth Rate (2017-2028)

    • Figure Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Growth Rate (2017-2028)

    • Table APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, by Type (2017-2028)

    • Table APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share, by Type (2017-2028)

    • Figure APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share, by Type (2017-2028)

    • Table APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, by Application (2017-2028)

    • Table APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share, by Application (2017-2028)

    • Figure APAC Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share, by Application (2017-2028)

    • Figure China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Growth Rate (2017-2028)

    • Figure Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Growth Rate (2017-2028)

    • Figure India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Value and Growth Rate (2017-2028)

    • Table Biogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Biogen Product Profiles, Application and Specification

    • Table Biogen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis AG Product Profiles, Application and Specification

    • Table Novartis AG Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bristol-Myers Squibb Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bristol-Myers Squibb Company Product Profiles, Application and Specification

    • Table Bristol-Myers Squibb Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Amgen Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Amgen Inc Product Profiles, Application and Specification

    • Table Amgen Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AbbVie Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AbbVie Inc Product Profiles, Application and Specification

    • Table AbbVie Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson Services, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Services, Inc Product Profiles, Application and Specification

    • Table Johnson & Johnson Services, Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Inc Product Profiles, Application and Specification

    • Table Pfizer Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline plc Product Profiles, Application and Specification

    • Table GlaxoSmithKline plc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck & Co, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck & Co, Inc Product Profiles, Application and Specification

    • Table Merck & Co, Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly and Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly and Company Product Profiles, Application and Specification

    • Table Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US